Congenital Heart Disease

Congenital Heart Disease is an open-access journal focusing on congenital heart disease in children and adults. Though the number of infants born with heart disease each year is relatively small (approximately 1% of the population), advances in treating such malformations have led to increased life spans for this population. Consequently, today most patients treated for congenital heart disease are over the age of 20. What are the special needs of adults with congenital heart disease? What are the latest developments in the care of the fetus, infants, and children? Who should treat these patients? How should they be treated?

Congenital Heart Disease focuses on these questions and more. Conceived as a forum for the most up-to-date information on congenital heart disease, the journal is led by Editor-in-Chief Vladimiro L. Vida, MD, Ph.D., Professor in Cardiac Surgery, University of Padua in Italy, as well as an international editorial board. Congenital Heart Disease publishes articles on heart disease as it relates to the following areas:

• Basic research of congenital heart disease

• Clinical pediatric and adult cardiology

• Cardiac imaging

• Preventive cardiology

• Diagnostic and interventional cardiac catheterization

• Electrophysiology

• Surgery

• Long-term follow-up, particularly as it relates to older children and adult congenital heart disease

• Exercise and exercise physiology in the congenital patient

• Post-op and critical care

• Common disorders such as syncope, chest pain, murmurs, as well as acquired disorders such as Kawasaki syndrome

The journal includes clinical studies, invited editorials, state-of-the-art reviews, case reports, articles focusing on the history and development of congenital heart disease, and CME material. Occasional issues focus on special topics.

Readership: Congenital Heart Disease was created for pediatric cardiologists; adult cardiologists who care for patients with congenital heart disease; pediatric and pediatric cardiology nurses; surgeons; radiologists; anesthesiologists; critical care physicians and nurses; and adult support staff involved in the care of patients with congenital heart disease.

《先天性心脏病》是一本开放获取期刊，专注于儿童和成人的先天性心脏病。尽管每年出生时患有心脏病的婴儿数量相对较少（约占总人口的 1%），但治疗此类畸形的进步已使这一人群的寿命延长。因此，今天接受先天性心脏病治疗的大多数患者年龄超过 20 岁。患有先天性心脏病的成年人有哪些特殊需求？胎儿、婴儿和儿童护理的最新进展是什么？谁应该治疗这些患者？他们应该如何治疗？

《先天性心脏病》关注这些问题以及更多问题。该期刊旨在成为先天性心脏病最新信息的论坛，由主编 Vladimiro L. Vida 博士（意大利帕多瓦大学心脏外科教授）以及国际编辑委员会领导。 《先天性心脏病》发表与以下领域相关的心脏病文章：

• 先天性心脏病的基础研究

• 临床儿科和成人心脏病学

• 心脏影像学

• 预防心脏病学

• 诊断和介入性心导管术

• 电生理学

• 外科手术

• 长期随访，特别是与大龄儿童和成人先天性心脏病相关的随访

• 先天性患者的运动和运动生理学

• 术后和重症监护

• 常见疾病，如晕厥、胸痛、杂音，以及后天性疾病，如川崎综合征

该期刊包括临床研究、特邀社论、最新评论、病例报告、侧重于先天性心脏病的历史和发展，以及 CME 材料。偶尔会有专题关注特殊主题。

读者群：《先天性心脏病》是为儿科心脏病专家、照顾先天性心脏病患者的成人心脏病专家、儿科和儿科心脏病学护士、外科医生、放射科医生、麻醉师、重症监护医生和护士以及参与照顾先天性心脏病患者的成人支持人员编写的。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映CARDIAC & CARDIOVASCULAR SYSTEMS领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为0.3，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。